Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Haematologica|June 11, 2026
Multicolor detection of chronic myeloid leukemia stem cells, including novel marker CD69, predicts survival and early hematological toxicityMartin Culen, Marianna Romzova, Dagmar Smitalova, et al.
Oncogenesis|December 5, 2017
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9Petra Vychytilova-Faltejskova, Jana Merhautova, Tana Machackova, et al.
Cancer Genomics & Proteomics|December 29, 2022
Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their OriginIvana Roskova, Marek Vecera, Lenka Radova, et al.
Scientific Reports|August 24, 2016
Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinomaHana Mlcochova, Tana Machackova, Anja Rabien, et al.
Leukemia|August 17, 2018
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cellsKaterina Cerna, Jan Oppelt, Vaclav Chochola, et al.
Vascular|May 20, 2022
Procalcitonin kinetics following abdominal aortic surgery and its value for postoperative intestinal ischaemia detectionTomas Novotny, Robert Staffa, Josef Tomandl, et al.
European Journal of Haematology|May 26, 2017
Deregulated expression of long non-coding RNA UCA1 in multiple myelomaLenka Sedlarikova, Barbora Gromesova, Veronika Kubaczkova, et al.
Annals of Hematology|October 29, 2018
Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemiaKristina Zaprazna, Kamila Reblova, Veronika Svobodova, et al.
British Journal of Haematology|September 22, 2016
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHVLucie Poppova, Pavlina Janovska, Karla Plevova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 7, 2012
Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemiaMichaela Spenerova, Petr Dzubak, Josef Srovnal, et al.
Pageof 8